CME PROGRAMS: (++++++++)

CME PROGRAMS Consider Rare: Suspecting and Diagnosing Hereditary Angioedema https://checkrare.com/learning/p-consider-rare-suspecting-and-diagnosing-hereditary-angioedema/ Jonathan A Bernstein, MD, Professor of Medicine at the University of Cincinnati describes the early symptoms of HAE and its clinical relevance and best practices to diagnose HAE more efficiently to reduce diagnostic delays. CREDITS: 0.5 CME | DURATION: 0.5 hours EXPIRES: 5/15/2026 | FEE: $0 Fabry Disease Research Highlights https://checkrare.com/learning/p-fabry-disease-research-highlights-2025/ Eric Wallace, MD, Professor of Medicine, Department of Nephrology at the University of Alabama Medical School, describes the latest research being presented to better manage individuals with Fabry disease and its clinical relevance. CREDITS: 0.5 CME | DURATION: 0.5 hours EXPIRES: 5/15/2026 | FEE: $0 Transforming Clinical Outcomes with Early Treatment of Lysosomal Disorders https://checkrare.com/learning/p-transforming-clinical-outcomes-with-early-treatment-of-lysosomal-disorders/ Ozlem Goker-Alpan MD, David F. Kronn, MD, Uma Ramaswami FRCPCH, MD, Liz Jalazo, MD, and Lindsay Torrice MSN, CPNP-PC, examine the evidence available to address how to monitor, and possibly treat, children with lysosomal diseases that were diagnosed by newborn screening or soon after birth. CREDITS: 1.00 CME | DURATION: 1 hour EXPIRES: 4/3/2026 | FEE: $0 GRIDS 2024 10th Anniversary: Optimizing the Efficacy and Safety of Therapy for Fabry Disease https://checkrare.com/learning/p-grids2024-session1-optimizing-the-efficacy-and-safety-of-therapy-for-fabry-disease/ David G. Warnock, MD, Professor of Medicine (Emeritus), University of Alabama at Birmingham, describes the first and second generation treatments for Fabry diseaseand explains the therapies in development for patients with Fabry disease. CREDITS: 0.75 CME | DURATION: 0.75 hours EXPIRES: 12/31/2025 | FEE: $0 Overview of Epigenetics and Epigenomics in Lysosomal Disorders https://checkrare.com/learning/p-grids2024-session2-overview-of-epigenetics-and-epigenomics-in-lysosomal-disorders/ Nahid Tayebi, PhD, Andrew Lieberman, MD, PhD, Andrés D. Klein, PhD, and David Smerkous, AI PhD, explain the applications of AI and Genomics in the diagnosis of lysosomal disease and the epigenetic mechanisms in lysosomal storage disorders. CREDITS: 1.25 CME | DURATION: 1.25 hours EXPIRES: 12/31/2025 | FEE: $0 Epigenetic and Epigenomics Signature in Lysosomal Disorders Pathology https://checkrare.com/learning/p-grids2024-session3-epigenetic-and-epigenomics-signature-in-lysosomal-disorders-pathology/ Detlev Boison, PhD, Dominique P. Germain, MD, PhD, Juozas Gordevicius, PhD, and Mia Horowitz, PhD, explain the epigenetic mechanisms in lysosomal storage disorder and the epigenetic inactivation of the autophagy-lysosomal system in Parkinson’s disease. CREDITS: 1.25 CME | DURATION: 1.25 hours EXPIRES: 12/31/2025 | FEE: $0 Epigenetic Modifiers as Therapeutic Targets https://checkrare.com/learning/p-grids2024-session4-epigenetic-modifiers-as-therapeutic-targets/ Katarina Trebušak Podkrajšek, PhD, Ali Beskok, PhD, Ying Sun, Professor, and Majdolen Istaiti (Joleen), B.Sc., MBA, analyze the development and delivery of ERT in neuronopathic Gaucher disease and explain the impact of the misfolding of the mutant glucocerebrosidase on the phenotypic heterogeneity of Gaucher disease. CREDITS: 1.25 CME | DURATION: 1.25 hours EXPIRES: 12/31/2025 | FEE: $0 Understanding the Global Differences in Lysosomal Disorders for Patient Care https://checkrare.com/learning/p-grids2024-session5-understanding-the-global-differences-in-lysosomal-disorders-for-patient-care/ Krista Casazza, PhD, RD, CSSD, Uma Ramaswami, FRCPCH, MD, Ida Vanessa D. Schwartz, MD, PhD, and Leyla Namazova-Baranova, MD, PhD, discuss the global overview of lysosomal disorders, epigenomics and geographic variations and the global changes in MPS epidemiology and related biology as revealed by transcriptomic studies. CREDITS: 2.00 CME | DURATION: 2.00 hours EXPIRES: 12/31/2025 | FEE: $0